External radiotherapy for prostatic cancers

Cancer Radiother. 2022 Feb-Apr;26(1-2):329-343. doi: 10.1016/j.canrad.2021.11.017. Epub 2021 Dec 23.

Abstract

We present the update of the recommendations of the French society of oncological radiotherapy on external radiotherapy of prostate cancer. External radiotherapy is intended for all localized prostate cancers, and more recently for oligometastatic prostate cancers. The irradiation techniques are detailed. Intensity-modulated radiotherapy combined with prostate image-guided radiotherapy is the recommended technique. A total dose of 74 to 80Gy is recommended in case of standard fractionation (2Gy per fraction). Moderate hypofractionation (total dose of 60Gy at a rate of 3Gy per fraction over 4 weeks) in the prostate has become a standard of therapy. Simultaneous integrated boost techniques can be used to treat lymph node areas. Extreme hypofractionation (35 to 40Gy in five fractions) using stereotactic body radiotherapy can be considered a therapeutic option to treat exclusively the prostate. The postoperative irradiation technique, indicated mainly in case of biological recurrence and lymph node involvement, is detailed.

Keywords: Cancer de la prostate; French society for radiation oncology; Guidelines; Prostate cancer; Radiation therapy; Radiothérapie; Recommandations; Société française de radiothérapie oncologique.

Publication types

  • Practice Guideline

MeSH terms

  • Dose Fractionation, Radiation
  • France
  • Humans
  • Lymphatic Irradiation / methods
  • Male
  • Neoplasm Recurrence, Local / radiotherapy
  • Organs at Risk / diagnostic imaging
  • Patient Positioning
  • Prostatectomy
  • Prostatic Neoplasms / diagnostic imaging
  • Prostatic Neoplasms / pathology
  • Prostatic Neoplasms / radiotherapy*
  • Prostatic Neoplasms / surgery
  • Radiation Oncology
  • Radiosurgery / methods
  • Radiotherapy, Image-Guided / methods
  • Radiotherapy, Intensity-Modulated / methods
  • Time Factors
  • Tumor Burden